• Something wrong with this record ?

Presence of Chlamydia trachomatis DNA in the amniotic fluid in women with preterm prelabor rupture of membranes

M. Kacerovsky, R. Romero, L. Pliskova, R. Bolehovska, H. Hornychova, A. Matejkova, H. Vosmikova, C. Andrys, M. Kolackova, P. Laudański, V. Pelantova, B. Jacobsson, I. Musilova

. 2021 ; 34 (10) : 1586-1597. [pub] 20190715

Language English Country Great Britain

Document type Journal Article

Grant support
HHSN275201300006C NICHD NIH HHS - United States
ZIA HD002400-27 Intramural NIH HHS - United States

OBJECTIVE: The primary aim of this study was to assess the rate and load of amniotic fluid Chlamydia trachomatis DNA and their associations with intra-amniotic infection and intra-uterine inflammatory complications in women with preterm prelabor rupture of membranes (PPROM). The secondary aim was to assess the short-term morbidity of newborns from PPROM pregnancies complicated by amniotic fluid C. trachomatis DNA. METHODS: A retrospective study of 788 women with singleton pregnancies complicated by PPROM between 24 + 0 and 36 + 6 weeks of gestation was performed. Transabdominal amniocenteses were performed at the time of admission. C. trachomatis DNA in the amniotic fluid was assessed by real-time polymerase chain reaction using a commercial AmpliSens® C. trachomatis/Ureaplasma/Mycoplasma hominis-FRT kit, and the level of Ct DNA was quantified. RESULTS: Amniotic fluid C. trachomatis DNA complicated 2% (16/788) of the PPROM pregnancies and was present in very low loads (median 57 copies DNA/mL). In addition to amniotic fluid C. trachomatis DNA, other bacteria were detected in 62% (10/16) of the C. trachomatis DNA-complicated PPROM pregnancies. Amniotic fluid C. trachomatis DNA was associated with intra-amniotic infection, histologic chorioamnionitis (HCA), and funisitis in 31%, 47%, and 33%, respectively. The presence of C. trachomatis DNA accompanied by Ureaplasma species in the amniotic fluid was associated with a higher rate of HCA than the presence of amniotic fluid C. trachomatis DNA alone. The composite neonatal morbidity in newborns from PPROM pregnancies with amniotic fluid C. trachomatis DNA was 31%. CONCLUSION: The presence of C. trachomatis DNA in the amniotic fluid is a relatively rare condition in PPROM. Amniotic fluid C. trachomatis DNA in PPROM is not related to intensive intra-amniotic and intr-auterine inflammatory responses or adverse short-term neonatal outcomes.

1st Department of Obstetrics and Gynecology Medical University of Warsaw Warsaw Poland

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic

Center for Molecular Medicine and Genetics Wayne State University Detroit MI USA

Department of Clinical Immunology and Allergy University Hospital Hradec Kralove Faculty of Medicine in Hradec Kralove Charles University Hradec Kralove Poland

Department of Epidemiology and Biostatistics Michigan State University East Lansing MI USA

Department of Genetics and Bioinformatics Domain of Health Data and Digitalisation Institute of Public Health Oslo Norway

Department of Infectious Diseases University Hospital Hradec Kralove Faculty of Medicine in Hradec Kralove Charles University Hradec Kralove Czech Republic

Department of Obstetrics and Gynecology Sahlgrenska Academy Gothenburg University Gothenburg Sweden

Department of Obstetrics and Gynecology University Hospital Hradec Kralove Faculty of Medicine in Hradec Kralove Charles University Hradec Kralove Czech Republic

Department of Obstetrics and Gynecology University of Michigan Ann Arbor MI USA

Fingerland Department of Pathology University Hospital Hradec Kralove Faculty of Medicine in Hradec Kralove Charles University Hradec Kralove Czech Republic

Institute of Clinical Biochemistry and Diagnostics University Hospital Hradec Kralove Faculty of Medicine in Hradec Kralove Charles University Hradec Kralove Czech Republic

Perinatology Research Branch Division of Obstetrics and Maternal Fetal Medicine Division of Intramural Research Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health U S Department of Health and Human Services Bethesda MD and Detroit MI USA

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018700
003      
CZ-PrNML
005      
20210830100300.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/14767058.2019.1640676 $2 doi
035    __
$a (PubMed)31272257
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kacerovsky, Marian $u Department of Obstetrics and Gynecology, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
245    10
$a Presence of Chlamydia trachomatis DNA in the amniotic fluid in women with preterm prelabor rupture of membranes / $c M. Kacerovsky, R. Romero, L. Pliskova, R. Bolehovska, H. Hornychova, A. Matejkova, H. Vosmikova, C. Andrys, M. Kolackova, P. Laudański, V. Pelantova, B. Jacobsson, I. Musilova
520    9_
$a OBJECTIVE: The primary aim of this study was to assess the rate and load of amniotic fluid Chlamydia trachomatis DNA and their associations with intra-amniotic infection and intra-uterine inflammatory complications in women with preterm prelabor rupture of membranes (PPROM). The secondary aim was to assess the short-term morbidity of newborns from PPROM pregnancies complicated by amniotic fluid C. trachomatis DNA. METHODS: A retrospective study of 788 women with singleton pregnancies complicated by PPROM between 24 + 0 and 36 + 6 weeks of gestation was performed. Transabdominal amniocenteses were performed at the time of admission. C. trachomatis DNA in the amniotic fluid was assessed by real-time polymerase chain reaction using a commercial AmpliSens® C. trachomatis/Ureaplasma/Mycoplasma hominis-FRT kit, and the level of Ct DNA was quantified. RESULTS: Amniotic fluid C. trachomatis DNA complicated 2% (16/788) of the PPROM pregnancies and was present in very low loads (median 57 copies DNA/mL). In addition to amniotic fluid C. trachomatis DNA, other bacteria were detected in 62% (10/16) of the C. trachomatis DNA-complicated PPROM pregnancies. Amniotic fluid C. trachomatis DNA was associated with intra-amniotic infection, histologic chorioamnionitis (HCA), and funisitis in 31%, 47%, and 33%, respectively. The presence of C. trachomatis DNA accompanied by Ureaplasma species in the amniotic fluid was associated with a higher rate of HCA than the presence of amniotic fluid C. trachomatis DNA alone. The composite neonatal morbidity in newborns from PPROM pregnancies with amniotic fluid C. trachomatis DNA was 31%. CONCLUSION: The presence of C. trachomatis DNA in the amniotic fluid is a relatively rare condition in PPROM. Amniotic fluid C. trachomatis DNA in PPROM is not related to intensive intra-amniotic and intr-auterine inflammatory responses or adverse short-term neonatal outcomes.
650    _2
$a plodová voda $7 D000653
650    _2
$a Chlamydia trachomatis $7 D002692
650    12
$a chorioamnionitida $x epidemiologie $7 D002821
650    _2
$a DNA $7 D004247
650    _2
$a ženské pohlaví $7 D005260
650    12
$a předčasný odtok plodové vody $7 D005322
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a interleukin-6 $7 D015850
650    _2
$a těhotenství $7 D011247
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
700    1_
$a Romero, Roberto $u Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U. S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA $u Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA $u Department of Epidemiology & Biostatistics, Michigan State University, East Lansing, MI, USA $u Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA
700    1_
$a Pliskova, Lenka $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Bolehovska, Radka $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Hornychova, Helena $u Fingerland Department of Pathology, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Matejkova, Adela $u Fingerland Department of Pathology, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Vosmikova, Hana $u Fingerland Department of Pathology, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Andrys, Ctirad $u Department of Clinical Immunology and Allergy, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Poland
700    1_
$a Kolackova, Martina $u Department of Clinical Immunology and Allergy, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Poland
700    1_
$a Laudański, Piotr $u 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland
700    1_
$a Pelantova, Vera $u Department of Infectious Diseases, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Jacobsson, Bo $u Department of Obstetrics and Gynecology, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden $u Department of Genetics and Bioinformatics, Domain of Health Data and Digitalisation, Institute of Public Health, Oslo, Norway
700    1_
$a Musilova, Ivana $u Department of Obstetrics and Gynecology, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
773    0_
$w MED00007048 $t The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians $x 1476-4954 $g Roč. 34, č. 10 (2021), s. 1586-1597
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31272257 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100301 $b ABA008
999    __
$a ok $b bmc $g 1689715 $s 1139146
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 34 $c 10 $d 1586-1597 $e 20190715 $i 1476-4954 $m Journal of maternal-fetal & neonatal medicine $n J Matern Fetal Neonatal Med $x MED00007048
GRA    __
$a HHSN275201300006C $p NICHD NIH HHS $2 United States
GRA    __
$a ZIA HD002400-27 $p Intramural NIH HHS $2 United States
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...